Polishing the crystal ball: mining multi-omics data in dermatomyositis.

Area of Science:

• Biomedical Research
• Genomics and Precision Medicine

Background:

• Precision medicine tailors healthcare based on individual variability at the molecular level.
• Multi-omics studies (epigenomics, genomics, transcriptomics, proteomics, microbiomics, metabolomics) generate vast datasets for biomarker discovery.
• Current dermatomyositis (DM) diagnosis and treatment often rely on a trial-and-error approach due to disease heterogeneity.

Purpose of the Study:

• To review omics-based research in dermatomyositis (DM).
• To explore the practical applications of multi-omics data in guiding clinical decisions for DM.
• To highlight the potential of personalized medicine in optimizing patient outcomes for DM.

Main Methods:

• Review of existing literature on omics research in DM.
• Analysis of how multi-omics data can be integrated with conventional diagnostic methods (serologic, histopathologic, radiologic, electrophysiologic).
• Emphasis on the importance of clinical findings in conjunction with multi-omics data.

Main Results:

• Multi-omics data holds potential for discovering clinically relevant biomarkers in DM.
• Integrating multi-omics with clinical data can significantly enhance diagnostic accuracy, therapeutic selection, and prognostic prediction for DM.
• Personalized treatment strategies can maximize benefits and minimize harm for DM patients.

Conclusions:

• Omics-based research is crucial for advancing precision medicine in DM.
• An individualized approach combining multi-omics data with clinical assessment is vital for optimizing DM patient care.
• This review underscores the promising role of omics in transforming DM management and improving patient outcomes.